Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin Intervention for Stroke Prevention
NCT00004734Phase 3Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Sep 1996
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of folic acid, pyridoxine and cyanocobalamin in stroke and myocardial infarction (MI) (2 arms), sponsored by National Institute of Neurological Disorders and Stroke. Primary endpoint: Recurrence of stroke or occurrence of myocardial infarction. Started Sep 1996; status: completed.
02
Drugs
folic acidpyridoxinecyanocobalamin
03
Conditions
strokemyocardial infarction (MI)
Beyond the preview
Go deeper on NCT00004734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004734.